{"id":"NCT01701362","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain","officialTitle":"A Randomized Double Blind Placebo Controlled Parallel Group Study Of The Efficacy And Safety Of Pregabalin (Bid) In Subjects With Post-traumatic Peripheral Neuropathic Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10","primaryCompletion":"2015-08","completion":"2015-08","firstPosted":"2012-10-05","resultsPosted":"2017-06-07","lastUpdate":"2021-01-28"},"enrollment":542,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Neuropathic Pain"],"interventions":[{"type":"DRUG","name":"pregabalin","otherNames":["Lyrica, PD-144723"]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"pregabalin","type":"ACTIVE_COMPARATOR"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is designed to investigate if pregabalin is effective in treating neuropathic (nerve) pain resulting from peripheral nerve trauma due to a traumatic or surgical event such as, for example, motor vehicle accident, fall, sports injury, knee or hip replacement, hernia repair, thoracotomy, mastectomy, focal/localized burns or crush injury.","primaryOutcome":{"measure":"Baseline Mean Pain Score","timeFrame":"Baseline","effectByArm":[{"arm":"Pregabalin","deltaMin":6.41,"sd":1.3},{"arm":"Placebo","deltaMin":6.54,"sd":1.3}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":156,"countries":["United States","Bulgaria","Canada","Croatia","Denmark","Germany","Hungary","Poland","Puerto Rico","Romania","South Africa","South Korea","Sweden"]},"refs":{"pmids":["30242745"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081279&StudyName=Placebo-controlled%20safety%20and%20efficacy%20study%20of%20pregabalin%20in%20subjects%20with%20post-traumatic%20peripheral%20neuropathic%20pain"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":274},"commonTop":["Dizziness","Somnolence","Fatigue","Nausea"]}}